EDITORIAL article
Front. Surg.
Sec. Surgical Oncology
Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1665001
This article is part of the Research TopicRecent Advances and New Challenges in Minimally Invasive Surgery and Chemotherapy for Colorectal Cancer-volume 2View all 8 articles
Editorial: Recent Advances and New Challenges in Minimally Invasive Surgery and Chemotherapy for Colorectal Cancer
Provisionally accepted
- Hanwa Memorial Hospital, Osaka, Japan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
underscoring its value in comprehensive local and systemic disease control (https://www.frontiersin.org/articles/10.3389/fonc.2024.1468279/full).The role of robotics in minimally invasive colorectal surgery continues to expand, as discussed in two key contributions. In a single-center comparative study, Wang et al. found that robotic-assisted surgery, while associated with longer operative times and higher costs, achieved similar clinical outcomes to laparoscopy in terms of complications, hospital stay, and oncologic integrity (https://www.frontiersin.org/articles/10.3389/fonc.2024.1507323/full). Chen et al. offered a broader perspective with a narrative review detailing the clinical advantages of robotic surgery and its integration into multidisciplinary treatment pathways, while highlighting current limitations such as lack of tactile feedback and economic constraints (https://www.frontiersin.org/articles/10.3389/fonc.2025.1502014/full).Accurate risk prediction remains a cornerstone of personalized oncology. Huang et al. Altogether, this second volume underscores the continued innovation, diversification, and integration across surgical and medical disciplines in the management of CRC. While the data presented offer significant promise, they also reinforce the need for ongoing clinical trials, cost-benefit analyses, and the standardization of protocols-particularly in robotic surgery and neoadjuvant regimens.We would like to thank all authors, reviewers, and editors for their scientific contributions and collaboration. In particular, we extend our sincere gratitude to Professor Nobu Oshima for his valued support and dedication as co-editor of this Research Topic. His contributions were instrumental in ensuring the quality and cohesion of this collection.We hope this volume serves as both a reference and an inspiration for future studies aiming to optimize the treatment and outcomes of patients with colorectal cancer.
Keywords: colorectal cancer, chemotherapy, minimally invasive surgery, laparoscopic surgery, robotic surgery
Received: 13 Jul 2025; Accepted: 29 Jul 2025.
Copyright: © 2025 Hashida. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Hiroki Hashida, Hanwa Memorial Hospital, Osaka, Japan
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.